Kinetic-Pharmacodynamic Model of Chemotherapy-Induced Peripheral Neuropathy in Patients with Metastatic Breast Cancer Treated with Paclitaxel, Nab-Paclitaxel, or Ixabepilone: CALGB 40502 (Alliance)-Reference-Cited by-同舟云学术

Kinetic-Pharmacodynamic Model of Chemotherapy-Induced Peripheral Neuropathy in Patients with Metastatic Breast Cancer Treated with Paclitaxel, Nab-Paclitaxel, or Ixabepilone: CALGB 40502 (Alliance)

Published:2017-06-15 Issue:5 Volume:19 Page:1411-1423
ISSN:1550-7416
Container-title:The AAPS Journal
language:en
Short-container-title:AAPS J

Author:

Mehrotra Shailly,Sharma Manish R.,Gray Elizabeth,Wu Kehua,Barry William T.,Hudis Clifford,Winer Eric P.,Lyss Alan P.,Toppmeyer Deborah L.,Moreno-Aspitia Alvaro,Lad Thomas E.,Valasco Mario,Overmoyer Beth,Rugo Hope,Ratain Mark J.,Gobburu Jogarao V.

Publisher

Springer Science and Business Media LLC

Subject

Pharmaceutical Science

Link

http://link.springer.com/article/10.1208/s12248-017-0101-9/fulltext.html

Reference39 articles.

1. Schloss JM, Colosimo M, Airey C, Masci PP, Linnane AW, Vitetta L. Nutraceuticals and chemotherapy induced peripheral neuropathy (CIPN): a systematic review. Clin Nutr. 2013;32(6):888–93.

2. Mantyh PW. Cancer pain and its impact on diagnosis, survival and quality of life. Nat Rev Neurosci. 2006;7(10):797–809.

3. Hershman DL, Lacchetti C, Dworkin RH, Smith EML, Bleeker J, Cavaletti G, et al. Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: american society of clinical oncology clinical practice guideline. J Clin Oncol. 2014;32(18):1941–67.

4. Park SB, Lin CS-Y, Krishnan AV, Friedlander ML, Lewis CR, Kiernan MC. Early, progressive, and sustained dysfunction of sensory axons underlies paclitaxel-induced neuropathy. Muscle Nerve. 2011;43(3):367–74.

5. Smith EML, Pang H, Cirrincione C, Fleishman S, Paskett ED, Ahles T, et al. Effect of duloxetine on pain, function and quality of life among patients with chemotherapy-induced peripheral neuropathy. JAMA. 2013;309(13):1359–67.

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical and Structural Highlights for Nanoparticle Formulations of Anticancer Drugs;Handbook of Oncobiology: From Basic to Clinical Sciences;2024

2. Clinical and Structural Highlights for Nanoparticle Formulations of Anticancer Drugs;Handbook of Oncobiology: From Basic to Clinical Sciences;2023

3. Redox-sensitive TRP channels: a promising pharmacological target in chemotherapy-induced peripheral neuropathy;Expert Opinion on Therapeutic Targets;2021-07-03

4. Time-to-Event Analysis of Paclitaxel-Associated Peripheral Neuropathy in Advanced Non–Small-Cell Lung Cancer Highlighting Key Influential Treatment/Patient Factors;Journal of Pharmacology and Experimental Therapeutics;2020-10-02

5. Genetic variation in EPHA contributes to sensitivity to paclitaxel‐induced peripheral neuropathy;British Journal of Clinical Pharmacology;2020-02-04